Transcatheter Mitral Valve Repair or Replacement

Transcatheter Mitral Valve Repair or Replacement: Competitive or Complementary?

Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt

Standard

Transcatheter Mitral Valve Repair or Replacement : Competitive or Complementary? / Xiling, Zhang; Puehler, Thomas; Sondergaard, Lars; Frank, Derk; Seoudy, Hatim; Mohammad, Baland; Müller, Oliver J.; Sellers, Stephanie; Meier, David; Sathananthan, Janarthanan; Lutter, Georg.

I: Journal of Clinical Medicine, Bind 11, Nr. 12, 3377, 2022.

Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt

Harvard

Xiling, Z, Puehler, T, Sondergaard, L, Frank, D, Seoudy, H, Mohammad, B, Müller, OJ, Sellers, S, Meier, D, Sathananthan, J & Lutter, G 2022, 'Transcatheter Mitral Valve Repair or Replacement: Competitive or Complementary?', Journal of Clinical Medicine, bind 11, nr. 12, 3377. https://doi.org/10.3390/jcm11123377

APA

Xiling, Z., Puehler, T., Sondergaard, L., Frank, D., Seoudy, H., Mohammad, B., Müller, O. J., Sellers, S., Meier, D., Sathananthan, J., & Lutter, G. (2022). Transcatheter Mitral Valve Repair or Replacement: Competitive or Complementary? Journal of Clinical Medicine, 11(12), [3377]. https://doi.org/10.3390/jcm11123377

Vancouver

Xiling Z, Puehler T, Sondergaard L, Frank D, Seoudy H, Mohammad B o.a. Transcatheter Mitral Valve Repair or Replacement: Competitive or Complementary? Journal of Clinical Medicine. 2022;11(12). 3377. https://doi.org/10.3390/jcm11123377

Author

Xiling, Zhang ; Puehler, Thomas ; Sondergaard, Lars ; Frank, Derk ; Seoudy, Hatim ; Mohammad, Baland ; Müller, Oliver J. ; Sellers, Stephanie ; Meier, David ; Sathananthan, Janarthanan ; Lutter, Georg. / Transcatheter Mitral Valve Repair or Replacement : Competitive or Complementary?. I: Journal of Clinical Medicine. 2022 ; Bind 11, Nr. 12.

Bibtex

@article{432820d080e64ac19d595b6e7d96e938,

title = "Transcatheter Mitral Valve Repair or Replacement: Competitive or Complementary?",

abstract = "Over the last two decades, transcatheter devices have been developed to repair or replace diseased mitral valves (MV). Transcatheter mitral valve repair (TMVr) devices have been proven to be efficient and safe, but many anatomical structures are not compatible with these technologies. The most significant advantage of transcatheter mitral valve replacement (TMVR) over transcatheter repair is the greater and more reliable reduction in mitral regurgitation. However, there are also potential disadvantages. This review introduces the newest TMVr and TMVR devices and presents clinical trial data to identify current challenges and directions for future research.",

keywords = "access, approach, endovascular, mitral insufficiency, mitral regurgitation, percutaneous, transcatheter mitral valve repair, transcatheter mitral valve replacement, transcatheter technology, transluminal",

author = "Zhang Xiling and Thomas Puehler and Lars Sondergaard and Derk Frank and Hatim Seoudy and Baland Mohammad and M{\"u}ller, {Oliver J.} and Stephanie Sellers and David Meier and Janarthanan Sathananthan and Georg Lutter",

note = "Publisher Copyright: {\textcopyright} 2022 by the authors. Licensee MDPI, Basel, Switzerland.",

year = "2022",

doi = "10.3390/jcm11123377",

language = "English",

volume = "11",

journal = "Journal of Clinical Medicine",

issn = "2077-0383",

publisher = "M D P I AG",

number = "12",

}

RIS

TY - JOUR

T1 - Transcatheter Mitral Valve Repair or Replacement

T2 - Competitive or Complementary?

AU - Xiling, Zhang

AU - Puehler, Thomas

AU - Sondergaard, Lars

AU - Frank, Derk

AU - Seoudy, Hatim

AU - Mohammad, Baland

AU - Müller, Oliver J.

AU - Sellers, Stephanie

AU - Meier, David

AU - Sathananthan, Janarthanan

AU - Lutter, Georg

PY - 2022

Y1 - 2022

N2 - Over the last two decades, transcatheter devices have been developed to repair or replace diseased mitral valves (MV). Transcatheter mitral valve repair (TMVr) devices have been proven to be efficient and safe, but many anatomical structures are not compatible with these technologies. The most significant advantage of transcatheter mitral valve replacement (TMVR) over transcatheter repair is the greater and more reliable reduction in mitral regurgitation. However, there are also potential disadvantages. This review introduces the newest TMVr and TMVR devices and presents clinical trial data to identify current challenges and directions for future research.

AB - Over the last two decades, transcatheter devices have been developed to repair or replace diseased mitral valves (MV). Transcatheter mitral valve repair (TMVr) devices have been proven to be efficient and safe, but many anatomical structures are not compatible with these technologies. The most significant advantage of transcatheter mitral valve replacement (TMVR) over transcatheter repair is the greater and more reliable reduction in mitral regurgitation. However, there are also potential disadvantages. This review introduces the newest TMVr and TMVR devices and presents clinical trial data to identify current challenges and directions for future research.

KW - access

KW - approach

KW - endovascular

KW - mitral insufficiency

KW - mitral regurgitation

KW - percutaneous

KW - transcatheter mitral valve repair

KW - transcatheter mitral valve replacement

KW - transcatheter technology

KW - transluminal

U2 - 10.3390/jcm11123377

DO - 10.3390/jcm11123377

M3 - Review

C2 - 35743448

AN - SCOPUS:85132071448

VL - 11

JO - Journal of Clinical Medicine

JF - Journal of Clinical Medicine

SN - 2077-0383

IS - 12

M1 - 3377

ER -

ID: 321959705